These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28439409)

  • 1. Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration.
    Li Y; Peer J; Zhao R; Xu Y; Wu B; Wang Y; Tian C; Huang Y; Zheng J
    Transl Neurodegener; 2017; 6():10. PubMed ID: 28439409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice.
    Wang Y; Li Y; Zhao R; Wu B; Lanoha B; Tong Z; Peer J; Liu J; Xiong H; Huang Y; Zheng J
    Brain Behav Immun; 2017 Nov; 66():135-145. PubMed ID: 28624534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminase Affects the Transcriptional Activity of Peroxisome Proliferator-Activated Receptor γ (PPARγ) via Direct Interaction.
    de Guzzi Cassago CA; Dias MM; Pinheiro MP; Pasquali CC; Bastos ACS; Islam Z; Consonni SR; de Oliveira JF; Gomes EM; Ascenção CFR; Honorato R; Pauletti BA; Indolfo NC; Filho HVR; de Oliveira PSL; Figueira ACM; Paes Leme AF; Ambrosio ALB; Dias SMG
    Biochemistry; 2018 Nov; 57(44):6293-6307. PubMed ID: 30295466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migration.
    Ascenção CFR; Nagampalli RSK; Islam Z; Pinheiro MP; Menezes Dos Reis L; Pauletti BA; de Guzzi Cassago CA; Granato DC; Paes Leme AF; Dias SMG
    Biochimie; 2018 Nov; 154():69-76. PubMed ID: 30092248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein-Barr Virus Infected Cells.
    Krishna G; Soman Pillai V; Valiya Veettil M
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32727118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
    Masamha CP; Xia Z; Peart N; Collum S; Li W; Wagner EJ; Shyu AB
    RNA; 2016 Jun; 22(6):830-8. PubMed ID: 27095025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase.
    Kenny J; Bao Y; Hamm B; Taylor L; Toth A; Wagers B; Curthoys NP
    Protein Expr Purif; 2003 Sep; 31(1):140-8. PubMed ID: 12963351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFα increases STAT3-mediated expression of glutaminase isoform KGA in cultured rat astrocytes.
    Milewski K; Bogacińska-Karaś M; Hilgier W; Albrecht J; Zielińska M
    Cytokine; 2019 Nov; 123():154774. PubMed ID: 31344597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells.
    Zhu M; Fang J; Zhang J; Zhang Z; Xie J; Yu Y; Ruan JJ; Chen Z; Hou W; Yang G; Su W; Ruan BH
    Anal Chem; 2017 Feb; 89(3):1689-1696. PubMed ID: 28208301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels.
    Buschdorf JP; Li Chew L; Zhang B; Cao Q; Liang FY; Liou YC; Zhou YT; Low BC
    J Cell Sci; 2006 Aug; 119(Pt 16):3337-50. PubMed ID: 16899818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.
    Pasquali CC; Islam Z; Adamoski D; Ferreira IM; Righeto RD; Bettini J; Portugal RV; Yue WW; Gonzalez A; Dias SMG; Ambrosio ALB
    J Biol Chem; 2017 Jul; 292(27):11572-11585. PubMed ID: 28526749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity and species variation of the kidney-type glutaminase gene.
    Porter LD; Ibrahim H; Taylor L; Curthoys NP
    Physiol Genomics; 2002; 9(3):157-66. PubMed ID: 12045296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.
    Szeliga M; Ćwikła J; Obara-Michlewska M; Cichocki A; Albrecht J
    Exp Mol Pathol; 2016 Feb; 100(1):74-8. PubMed ID: 26581715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen: Mechanisms of Glutamate Dehydrogenase and Glutaminase Enzyme Inhibition.
    Yu Y; Jin Y; Zhou J; Ruan H; Zhao H; Lu S; Zhang Y; Li D; Ji X; Ruan BH
    ACS Chem Biol; 2017 Dec; 12(12):3003-3011. PubMed ID: 29072450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylarsinic acid promotes degradation of glutaminase C by mitochondrial Lon protease.
    Kita K; Suzuki T; Ochi T
    J Biol Chem; 2012 May; 287(22):18163-72. PubMed ID: 22493432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.
    Gross MI; Demo SD; Dennison JB; Chen L; Chernov-Rogan T; Goyal B; Janes JR; Laidig GJ; Lewis ER; Li J; Mackinnon AL; Parlati F; Rodriguez ML; Shwonek PJ; Sjogren EB; Stanton TF; Wang T; Yang J; Zhao F; Bennett MK
    Mol Cancer Ther; 2014 Apr; 13(4):890-901. PubMed ID: 24523301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors.
    Szeliga M; Matyja E; Obara M; Grajkowska W; Czernicki T; Albrecht J
    Neurochem Res; 2008 May; 33(5):808-13. PubMed ID: 17940881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors.
    Thomas AG; Rojas C; Tanega C; Shen M; Simeonov A; Boxer MB; Auld DS; Ferraris DV; Tsukamoto T; Slusher BS
    Biochem Biophys Res Commun; 2013 Aug; 438(2):243-8. PubMed ID: 23850693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).
    Thangavelu K; Chong QY; Low BC; Sivaraman J
    Sci Rep; 2014 Jan; 4():3827. PubMed ID: 24451979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.